Wendy Clemens Trigona
About Wendy Clemens Trigona
Wendy Clemens Trigona is the Vice President of Early Development at Bristol-Myers Squibb in Princeton, NJ, with extensive experience in autoimmunity, oncology, immuno-oncology, and infectious disease.
Current Position at Bristol-Myers Squibb
Wendy Clemens Trigona currently serves as the Vice President of Early Development at Bristol-Myers Squibb, based in Princeton, NJ. In this capacity, she plays a critical role in driving early development strategies, integrating her extensive expertise in translational sciences and innovative trial design to advance the company's drug development pipeline.
Previous Roles and Experience
Before her current role, Wendy Clemens Trigona held several high-level positions in various pharmaceutical companies. Notable positions include Executive Director at Tmunity Therapeutics Incorporated in 2019, Vice President of Clinical Development at Nektar Therapeutics from 2018 to 2019, and various roles at Bristol-Myers Squibb including Executive Director, Director, Associate Director, Principal Scientist, and Senior Scientist. Her tenure at these companies reflects her deep experience in clinical and early drug development, particularly in the fields of oncology and immunology.
Educational Background
Wendy Clemens Trigona holds a PhD in Physiology/Immunology from Penn State University, completed in three years between 2002 and 2005. Prior to that, she earned an MS in Veterinary Immunology from the University of Missouri-Columbia between 1996 and 1998. Her academic career began with a BS in Animal Science, with a minor in Microbiology, from Penn State University, which she completed from 1992 to 1996. Her educational background has provided a solid foundation for her subsequent career in drug development and translational sciences.
Area of Expertise
Wendy Clemens Trigona has developed a versatile background in autoimmunity, oncology, immuno-oncology, and infectious disease. She leverages her broad understanding of disease pathophysiology and innovative trial design to accelerate drug development strategies. Her strong expertise in translational sciences allows her to execute biomarker-driven correlative studies effectively. This blend of skills has proven invaluable in the execution of her roles in the pharmaceutical industry.
Professional Development and Network
Throughout her career, Wendy Clemens Trigona has demonstrated a proven track record for developing strategic relationships both within companies and across the industry. She excels in bridging strategies in various matrix environments, fostering collaborations with academic partners and cross-industry stakeholders. These relationships have been vital in advancing her projects and achieving success in her various roles.